JP2018508084A - 逆指向分析（Ｒｅｖｅｒｓｅｄ−ｄｉｒｅｃｔｅｄａｎａｌｙｓｉｓ）による証拠に基づく植物の有効成分の検出方法 - Google Patents

逆指向分析（Ｒｅｖｅｒｓｅｄ−ｄｉｒｅｃｔｅｄａｎａｌｙｓｉｓ）による証拠に基づく植物の有効成分の検出方法 Download PDF

Info

Publication number
JP2018508084A
JP2018508084A JP2017548209A JP2017548209A JP2018508084A JP 2018508084 A JP2018508084 A JP 2018508084A JP 2017548209 A JP2017548209 A JP 2017548209A JP 2017548209 A JP2017548209 A JP 2017548209A JP 2018508084 A JP2018508084 A JP 2018508084A
Authority
JP
Japan
Prior art keywords
patient
compounds
patients
herbs
analyzing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017548209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018508084A5 (https=
Inventor
チャン，チェンイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2018508084A publication Critical patent/JP2018508084A/ja
Publication of JP2018508084A5 publication Critical patent/JP2018508084A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4854—Diagnosis based on concepts of alternative medicine, e.g. homeopathy or non-orthodox
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/90—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to alternative medicines, e.g. homeopathy or oriental medicines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Artificial Intelligence (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Databases & Information Systems (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Bioethics (AREA)
  • Theoretical Computer Science (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2017548209A 2015-03-13 2016-03-03 逆指向分析（Ｒｅｖｅｒｓｅｄ−ｄｉｒｅｃｔｅｄａｎａｌｙｓｉｓ）による証拠に基づく植物の有効成分の検出方法 Pending JP2018508084A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562177349P 2015-03-13 2015-03-13
US62/177,349 2015-03-13
US14/866,924 2015-09-26
US14/866,924 US20160085941A1 (en) 2015-03-13 2015-09-26 Method of Discovery of Effective Components in Herbals Based on Evidences by Reversed-directed Analysis
PCT/US2016/020789 WO2016148936A1 (en) 2015-03-13 2016-03-03 Method of discovery of effective components in herbals based on evidences by reversed-directed analysis

Publications (2)

Publication Number Publication Date
JP2018508084A true JP2018508084A (ja) 2018-03-22
JP2018508084A5 JP2018508084A5 (https=) 2019-05-09

Family

ID=55525998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017548209A Pending JP2018508084A (ja) 2015-03-13 2016-03-03 逆指向分析（Ｒｅｖｅｒｓｅｄ−ｄｉｒｅｃｔｅｄａｎａｌｙｓｉｓ）による証拠に基づく植物の有効成分の検出方法

Country Status (6)

Country Link
US (1) US20160085941A1 (https=)
EP (1) EP3268926A4 (https=)
JP (1) JP2018508084A (https=)
CN (1) CN108351328A (https=)
AU (1) AU2016233772A1 (https=)
WO (1) WO2016148936A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021132988A1 (ko) * 2019-12-27 2021-07-01 한국식품연구원 식치 정보의 관리 방법 및 장치

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118671248B (zh) * 2024-08-23 2024-12-03 山东齐都药业有限公司 逆向分析聚原酸酯原料的方法及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001357131A (ja) * 2000-06-12 2001-12-26 Kanai Tokichi Shoten:Kk 通信ネットワークを介して漢方薬の処方を提供する方法
JP2008097154A (ja) * 2006-10-06 2008-04-24 Fujitsu Ltd 相互作用分析プログラムおよび相互作用分析装置
JP2010524055A (ja) * 2007-03-30 2010-07-15 ９８９８リミテッド 天然物開発のための薬剤プラットフォーム技術
JP2013012025A (ja) * 2011-06-29 2013-01-17 Fujifilm Corp 診療支援システムおよび方法、並びに、プログラム

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113907A (en) * 1997-04-15 2000-09-05 University Of Southern California Pharmaceutical grade St. John's Wort
US6156291A (en) * 1997-08-28 2000-12-05 Cv Technologies Inc. Chemical and pharmacological standardization of herbal extracts
JPH11193240A (ja) * 1997-12-26 1999-07-21 Meiji Milk Prod Co Ltd 脂質代謝改善組成物
US20050283385A1 (en) * 2004-06-21 2005-12-22 The Permanente Medical Group, Inc. Individualized healthcare management system
CN103065066B (zh) * 2013-01-22 2015-10-28 四川大学 基于药物组合网络的药物联合作用预测方法
US20150339442A1 (en) * 2013-12-04 2015-11-26 Mark Oleynik Computational medical treatment plan method and system with mass medical analysis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001357131A (ja) * 2000-06-12 2001-12-26 Kanai Tokichi Shoten:Kk 通信ネットワークを介して漢方薬の処方を提供する方法
JP2008097154A (ja) * 2006-10-06 2008-04-24 Fujitsu Ltd 相互作用分析プログラムおよび相互作用分析装置
JP2010524055A (ja) * 2007-03-30 2010-07-15 ９８９８リミテッド 天然物開発のための薬剤プラットフォーム技術
JP2013012025A (ja) * 2011-06-29 2013-01-17 Fujifilm Corp 診療支援システムおよび方法、並びに、プログラム

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021132988A1 (ko) * 2019-12-27 2021-07-01 한국식품연구원 식치 정보의 관리 방법 및 장치
KR20210083945A (ko) * 2019-12-27 2021-07-07 한국식품연구원 식치 정보의 관리 방법 및 장치
KR102376173B1 (ko) * 2019-12-27 2022-03-21 한국식품연구원 식치 정보의 관리 방법 및 장치

Also Published As

Publication number Publication date
WO2016148936A1 (en) 2016-09-22
AU2016233772A1 (en) 2017-08-17
US20160085941A1 (en) 2016-03-24
WO2016148936A8 (en) 2017-03-30
EP3268926A1 (en) 2018-01-17
CN108351328A (zh) 2018-07-31
EP3268926A4 (en) 2018-12-05

Similar Documents

Publication Publication Date Title
Siemens et al. Pharmacological interventions for pruritus in adult palliative care patients
Maes et al. Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway
Forssell et al. Occlusal treatments in temporomandibular disorders: a qualitative systematic review of randomized controlled trials
Xander et al. Pharmacological interventions for pruritus in adult palliative care patients
Waffenschmidt et al. Simple search techniques in PubMed are potentially suitable for evaluating the completeness of systematic reviews
Chen et al. Mapping normative muscle health metrics across the aging continuum: a multinational study pooling data from eight cohorts in Japan, Malaysia and Taiwan
Boulet et al. Allergen‐induced early and late asthmatic responses to inhaled seasonal and perennial allergens
Kleefstra et al. Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC-17)
Franceschetti et al. Drugs in bone: Detectability of substances of toxicological interest in different states of preservation
Mendonça et al. Physical exercise is effective for neuropsychiatric symptoms in Alzheimer's disease: a systematic review
Mork et al. Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: results from the German INHIBIT registry
Alsubaie et al. Prevalence of obsessive compulsive disorder: a survey with Southern Saudi Arabian samples
Xu et al. Non-linear association between serum spermidine and mild cognitive impairment: Results from a cross-sectional and longitudinal study
Leal et al. Evaluative and discriminative properties of the Portuguese MacNew Heart Disease Health-related Quality of Life questionnaire
Jeon et al. Do somatic symptoms predict the severity of depression? A validation study of the Korean version of the depression and somatic symptoms scale
Christensen et al. Cervicothoracic angina identified by case history and palpation findings in patients with stable angina pectoris
JP2018508084A (ja) 逆指向分析（Ｒｅｖｅｒｓｅｄ−ｄｉｒｅｃｔｅｄａｎａｌｙｓｉｓ）による証拠に基づく植物の有効成分の検出方法
Narendran et al. Imaging cortical dopamine transmission in cocaine dependence: a [11C] FLB 457–amphetamine positron emission tomography study
Meini et al. Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment
Machado et al. Cognitive impairment and quality of life of patients subjected to hematopoietic stem cell transplantation
Hunter et al. Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes?
Sharma Use of patch testing for identifying allergen causing chronic urticaria
Melara et al. Longitudinal effects of breast cancer treatment on neural correlates of attention
Berge et al. Pre-treatment allergen-specific IgE analysis and outcomes of allergen immunotherapy
Milandari et al. Relationship Between Family Support With Compliance About The Treatment Of Hypertension Patients

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190301

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20190301

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190301

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200518

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201019

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210215